Comparison of a very low-calorie-ketogenic diet with a standard low-calorie diet in the treatment of obesity
- 5.8k Downloads
The global prevalence of obesity has significantly increased in most industrialized countries. Anti-obesity drugs are scarce, and indications to change their life style are impractical. Therefore, to identify diets able to produce significantly and maintained weight loss is mandatory. The present work evaluated the efficacy of a very low-calorie-ketogenic (VLCK) diet in obesity. A group of obese patients were randomized into two groups: the VLCK diet group and a standard low-calorie diet (LC group). The follow-up period was 12 months. Both groups received external support, counseling, to perform physical activity and adhered to the diet. The VLCK diet induced a 30–45 days of mild ketosis and significant effects on body weight within 15 days. At 2 months, the weight reductions in the VLCK diet and LC diet groups were 13.6 ± 3.9 and 4.8 ± 2.7 kg, respectively (p < 0.0001). At the end of the study, at 12 months, the weight reductions were 19.9 ± 12.3 and 7.0 ± 5.6 kg, respectively (p < 0.0001), and more than 88 % of patients in the VLCK diet group lost more of 10 % of their initial weight. Lean mass was practically unaffected. The VLCK diet was well tolerated and the side effects were moderate and transitory. In a group of obese patients, the VLCK diet was significantly more effective than a standard LC diet. At one year follow-up in the group with VLCK diet, most of the patients loss more than 10 % of their initial weight and lean mass was well preserved.
KeywordsLow-carbohydrate diet Fat mass Lean mass Ketosis Protein diet BMI Weight reduction Pronokal Program
We acknowledge the Pronokal Division of Protein Supplies SL Spain for providing free of charge the diet of the ketosis group.
BM, DB, AG, and FFC received advisory board fees and or research grants from Pronokal Protein Supplies Spain
- 2.F.F. Casanueva, B. Moreno, R. Rodríguez-Azeredo, C. Massien, P. Conthe, X. Formiguera et al., Relationship of abdominal obesity with cardiovascular disease, diabetes and hyperlipidaemia in Spain. Clin. Endocrinol. 73, 35–40 (2010)Google Scholar
- 6.L. Velazquez-Lopez, E. Gonzalez-Figueroa, P. Medina-Bravo, I. Pineda-Del Aguila, L. Avila-Jimenez, R. Ramos-Hernandez et al., Low calorie and carbohydrate diet: to improve the cardiovascular risk indicators in overweight or obese adults with prediabetes. Endocrine 43, 593–602 (2013)PubMedCrossRefGoogle Scholar
- 21.E. Hemmingsson, K. Johansson, J. Eriksson, J. Sundstrom, M. Neovius, C. Marcus, Weight loss and dropout during a commercial weight-loss program including a very-low-calorie diet, a low-calorie diet or restricted normal food: observational cohort study. Am. J. Clin. Nutr. 96, 953–961 (2012)PubMedCentralPubMedCrossRefGoogle Scholar
- 25.FAO/WHO/UNU Energy and protein requirements. Technical Report Series No 724. WorldHealthOrganization, Geneva, 1985Google Scholar
- 26.Recomendaciones nutricionales basadas en la evidencia para la prevencion y el tratamiento del sobrepeso y la obesidad en adultos, Rev. Esp. Obes. 10, suppl. 1 (2011)Google Scholar
- 28.SCOOP-VLCD task 7.3. Reports on tasks for scientific cooperation. Collection of data on products intended for use in very-low-calorie-diets. Report. Brussels. European Commission, September 2002Google Scholar
- 33.L. Sjöström, A. Rissanen, T. Andersen, M. Boldrin, A. Golay, H.P. Koppeschaar, M. Krempf, Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European multicentre orlistat study group. Lancet 352, 167–172 (1998)PubMedCrossRefGoogle Scholar
- 35.L.F. Van Gaal, Rissanen AM, Scheen AJ, Ziegler O, Rossner S, for the RIO-Europe Study Group. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1 year experience from the RIO-Europe study. Lancet 365, 1389–1397 (2005)PubMedCrossRefGoogle Scholar
- 42.M.M. Finucane, G.A. Stevens, M.J. Cowan, G. Danaei, J.K. Lin, C.J. Paciorek et al., National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 377, 557–567 (2011)PubMedCrossRefGoogle Scholar
- 44.K.F. Schulz, D.G. Altman, D. Moher, CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoSMed 7, e1000251 (2010)Google Scholar